BEVESPI AEROSPHERE

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, UK.

Active ingredients

The drug BEVESPI AEROSPHERE contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII V92SO9WP2I - GLYCOPYRROLATE
 

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways.

 
Read more about Glycopyrronium
2
UNII W34SHF8J2K - FORMOTEROL FUMARATE
 

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.

 
Read more about Eformoterol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 BEVESPI AEROSPHERE Pressurised inhalation, suspension MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R03AL07 R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1786596, 1831384
FI Lääkealan turvallisuus- ja kehittämiskeskus 124662, 415060
GB Medicines & Healthcare Products Regulatory Agency 393292
JP 医薬品医療機器総合機構 2259808G1020, 2259808G2027
LT Valstybinė vaistų kontrolės tarnyba 1086876, 1088672
NL Z-Index G-Standaard, PRK 200271
PL Rejestru Produktów Leczniczych 100416810
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W65410001
TR İlaç ve Tıbbi Cihaz Kurumu 8699786520035
US FDA, National Drug Code 0310-4600

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.